Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for ASTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1997. Start Trial.
Date Value
December 31, 2025 114.60M
December 31, 2024 52.20M
December 31, 2023 68.23M
December 31, 2022 82.13M
December 31, 2021 70.34M
December 31, 2020 46.16M
December 31, 2019 13.91M
December 31, 2018 26.10M
December 31, 2017 53.07M
March 31, 2017
March 31, 2016 -1.839M
March 31, 2015 -0.2719M
January 31, 2014 -1.478M
January 31, 2013 0.058M
January 31, 2012 -0.3855M
Date Value
January 31, 2011 -0.245M
January 31, 2010 -0.3381M
January 31, 2009 -0.6225M
December 31, 2007 -0.0131M
December 31, 2006 -0.016M
December 31, 2005 -0.0062M
December 31, 2004 -0.0002M
December 31, 2003 -0.0054M
December 31, 2002 -0.0061M
December 31, 2001 -0.0004M
December 31, 2000 0.0006M
December 31, 1999 -0.0041M
December 31, 1998 -0.0008M
December 31, 1997 -0.0017M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Starling Oncology, Inc. -24.59M
Agilon Health, Inc. -105.76M
Nakamoto, Inc. -23.51M
American Oncology Network, Inc. --
Nutex Health, Inc. 248.12M